Blog Archives

Introducing our largest capacity battery to date - the Tracer Ultra Battery

25/9/2016

Introducing the new Tracer Ultra Battery Pack.

If you are planning to travel with your CPAP machine while away from mains power, then you will need a compact battery to power your CPAP machine. We now stock two Tracer batteries; the Tracer Compact Battery and the Tracer Ultra Battery.

The Tracer Ultra Battery now lets CPAP users travel away from mains power for roughly *four nights with its large capacity size. Included in your purchase is a compact charger which will fully charge your Tracer 12V Ultra Battery in 14-20 hours. If you need a speedier charging time, then you can purchase a Tracer Fast Charger additionally which should fully charge your Tracer Ultra Battery in just 7-10 hours. The Tracer Ultra Battery is ideal for those needing battery power for a few nights on a camping trip or away from unreliable mains power, however please note that the Tracer Ultra does not meet airline guidelines so is not suitable for flight use.

If you need battery power for a shorter period of time such as a weekend break away, then you might be interested in the Tracer Compact battery. The Tracer Compact battery does meet airline guidelines thanks to it's lightweight and compact design; making it a great option for those wishing to use their CPAP machine on-flight. The Tracer 12V Compact Battery can power your machine for around *two nights. Included in your purchase is a compact standard charger which should fully charge your battery in 8-12 hours. You can also purchase a Tracer Fast Charger for this battery, which should fully charge it in 4-6 hours.

Please note: Running times will vary depending on your CPAP machine, pressure settings and other factors. Please see the respective product page for more accurate running times.

Fisher & Paykel launch new Nasal Pillows mask - Brevida

23/9/2016

Fisher & Paykel have launched their latest nasal pillows mask - Brevida, which provides nasal pillow users with maximum comfort and easy user compliance. Fisher & Paykel believe that they can restore user confidence with this mask and ensure that OSA sufferers can quickly adjust to using this mask while finding comfort.

Brevida features an AirPillow seal which inflates to form a soft pillow of air, while securing a firm seal in and around your nose. The headgear on the Brevida mask has been designed to make CPAP users lifestyles easier, with a velcro adjustable headgear strap that allows users to simply tighten or loosen the fit of the mask until it feels comfortable and secure.

For light sleepers, the Brevida mask is a great option as it features a washable diffuser on the bridge of the nose, reducing air draft and noise. The diffuser can be easily washed ensuring maximum hygiene levels can be kept.

To make fitting and cleaning your mask user friendly, Brevida features VisiBlue highlights so you can disassemble and reassemble your mask easily with subtle colour cues.

Find out more information on the Brevida Nasal Pillows mask by Fisher & Paykel here.

Brevida is the new nasal pillows mask by Fisher & Paykel that restores confidence in CPAP compliance.

DeVilbiss Healthcare welcome price cuts across the DeVilbiss Blue CPAP range

23/9/2016

It is the perfect time for those looking to order a CPAP machine. Whether you're new to CPAP therapy or looking for a new replacement machine, the DeVilbiss Blue range has you covered. Welcoming price cuts across the whole DeVilbiss Blue range, the high standard of data and performance machines are now reaching a similar price to other competitors.

With improved sensitivity, the DeVilbiss Blue CPAP's can differentiate and report simple Obstructive Sleep Apnoea from more complex disorders including Central Sleep Apnoea. Featuring SmartFlex and Flow Rounding technology, this CPAP machine has been made with user compliance in mind; providing maximum comfort to the user.

If you suffer from waking up with a dry mouth or nasal passage, then you might want to order the DeVilbiss Blue Humidifier that features PulseDose technology to utilise further comfort.

If you are interested in the DeVilbiss Blue range, click below to view the full range in detail on its respective page.

DeVilbiss Healthcare welcome large price cuts across the DeVilbiss Blue CPAP range.

BresoTec launches BresoDx® in the UK with Intus Healthcare

21/9/2016

BresoTec and Intus Healthcare announce distribution agreement to launch and sell BresoDx® in the United Kingdom

Toronto, Ontario, Canada, 5 September 2016 – BresoTec has entered into an exclusive distribution agreement with Intus Healthcare to launch BresoDx® in the UK. This marks the European launch of BresoDx®, the first cordless, single-user, home sleep test used as an aid in the diagnosis of sleep apnoea.

“We are delighted to make BresoDx® available to patients and consultants in the UK. This is the first step on our journey of global commercialisation and reach” says Julie Brogren, Chief Operating Officer and VP of Global Sales and Marketing. “Intus is an ideal partner in the UK. Intus has many years’ experience and a strong network in the field and we share the belief that there is a need for a reliable, simple and cost-effective device for diagnosing sleep apnoea”. Intus Healthcare has gained the exclusive rights for the marketing, distribution and sale of BresoDx® in the UK. “BresoDx® makes the diagnosis of sleep apnoea easy and accessible to more people. It is well validated and has a 95% correlation with the results of a traditional in-lab (PSG) sleep study” says Martin Heller, Managing Director of Intus Healthcare. “We are excited to be present at the European Respiratory Society’s Congress (ERS) with BresoTec to launch BresoDx®”.

About BresoTec
BresoTec Inc., a Canadian company based in Toronto, Ontario, develops, manufactures and sells products for the diagnosis and treatment of sleep disorders. BresoTec’s first product, BresoDx®, is an innovative device using breath sound and movement recording technology to aid in the diagnosis of sleep apnoea. It is the world’s first cordless, single-user, home sleep testing device for this purpose. The accuracy of BresoDx®versus the in-lab standard test for detecting sleep apnoea (polysomnography) has been validated in several clinical trials led by Drs. Hisham Alshaer and Douglas Bradley of the University Health Network. Such accuracy in a simple, cordless device establishes BresoDx® as a reliable, cost- effective and user-friendly home sleep test for consultants, patients and health care providers.

BresoDx® received regulatory approval from Health Canada in December 2014 and from the European Commission (CE marking) in February 2016.

The technology behind BresoDx® was developed by iDAPT Research at Toronto Rehabilitation Institute, iDAPT Research is the leading rehabilitation research center in the world. Toronto Rehabilitation Institute is a part of University Health Network (UHN) and is fully affiliated with the University of Toronto. BresoTec was founded by UHN and MaRS Innovation, a non-profit incubator that acts on behalf of 14 of Toronto’s top universities, institutions and research institutes, as well as the MaRS Discovery District. BresoTec’s technology is exclusively licensed from UHN.

About Intus Healthcare
Intus Healthcare founded in 2004, specialises in sleep disorders, specifically Sleep Disordered Breathing (SDB). Intus Healthcare have been helping people with SDB for many years with almost all the major brands around the world. Intus supplies both the NHS and private patients across 35+ different countries from their UK base.

About sleep apnoea
Sleep apnoea is a condition characterised by repetitive cessations of breathing during sleep that disrupt sleep and cause excessive daytime sleepiness. It affects around 10% of the adult population globally. It is treatable, but less than 15% of North Americans with the condition have been diagnosed; fewer elsewhere. Left untreated, sleep apnoea leads to serious health complications, including a 3–4 fold increase in the risk of hypertension, stroke and heart failure.Untreated sleep apnoea is also strongly associated with an increased risk of traffic accidents due to sleepiness.

The low rate of diagnosis is mainly due to the substantial cost and inconvenience of undergoing overnight testing in a sleep laboratory. This complex in-lab test is called polysomnography (PSG). BresoDx® is designed to meet the need for reliable, less costly and simpler means of diagnosing sleep apnoea.

BresoDX is launching in the UK and Republic of Ireland

1/9/2016

BresoDx is launching this Saturday at ERS in London and we are there to support them. We are pleased to announce that we are now the exclusive distributors of the BresoDx diagnostic device in the UK and Republic of Ireland.

BresoDx has been approved in Europe as an aid in the diagnosis of sleep apnoea. The innovative device uses proprietary acoustic and movement recording technology to detect apnoea events. It is a cordless, battery operated device that provides results with a 94-96% correlation to the current gold standard of PSG. It has the versatility to be used for independent patient use in the comfort of their own home, or with minimal assistance in a hospital ward or sleep clinic. BresoDx has been tested and validated for its accuracy in several clinical trials led by Drs. Hisham Alshaer and Douglas Bradley of the University Health Network. It is a reliable and cost effective solution that can enhance the field of sleep apnoea diagnosis for physicians, patients and health care providers.

To find out more about the BresoDx Sleep Apnoea Diagnostic device, click here.

Introducing our largest capacity battery to date - the Tracer Ultra Battery

Fisher & Paykel launch new Nasal Pillows mask - Brevida﻿

DeVilbiss Healthcare welcome price cuts across the DeVilbiss Blue CPAP range

BresoTec launches BresoDx® in the UK with Int﻿us Healthcare

BresoDX is launching in the UK and Republic of Ireland﻿

Archives

Fisher & Paykel launch new Nasal Pillows mask - Brevida

BresoTec launches BresoDx® in the UK with Intus Healthcare

BresoDX is launching in the UK and Republic of Ireland